Margaret Mbuchi

Margaret Mbuchi

Auto-generated profile, based on publicly available information

Margaret Mbuchi

Center for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2026 in medRxiv
Verified
Preprint
Open access
PDF file
JCJoao Cunha
Joao Cunha
AAAyenew Addisu
Ayenew Addisu
DMDaniel Matano
Daniel Matano
BYBrima M. Younis
Brima M. Younis
ABAlice Bayiyana
Alice Bayiyana
PKPaul M. Kaye
Paul M. Kaye
Background: Visceral leishmaniasis (VL) is the most severe form of leishmaniasis and is caused by parasites from the Leishmania donovani complex. VL is endemic in 54 countries, with East Africa (EA) accounting for ∼70% of the global burden. Therefore, there is a pressing need to prioritize VL research in EA. Transcriptomics analysis in rodent models and patients following treatment have shown that immune homeostasis is not restored by the end of treatment. However, comprehensive proteomic studies in VL remain scarce, and the few available studies were conducted outside EA. Methodology/Principal Findings: As a part of ImmStat@cure consortium, we used the Olink Reveal proximity extension assay to profile circulating proteins in VL patients from Ethiopia, Kenya and Sudan. By comparing patients at admission and 17 days after treatment with SSG-PM, we have identified a systemic Th1-cytotoxic inflammatory profile at admission, characterized by high abundance of IFNγ, IL-1B, IL-6, and the granzymes A and B. Chemokines with high abundance included CXCL8/10/11, CCL3, CCL4, CCL8, CXCL8 and CCL20, consistent with the recruitment of monocytes, macrophages, T cells, and NK cells. There were also evidence of immune regulation/exhaustion, with high levels of PD1, PD-L2, IDO1 and KYNU. Although the immune profiles were similar at admission, country specific differences were observed after treatment. Kenyan patients exhibited a sustained inflammatory profile and signatures of myeloid recruitment, characterized by high levels of IL-1B, IL-6 , IL-12A, CXCL8, CCL2, CCL3, CCL4 ,CCL7 and CEBPB. Sudanese patients showed signatures associated with lymphocyte activation and immune regulation. Conclusions/Significance: These results highlight the complexity of the immune changes associated with VL, identifying both core conserved profiles at admission and country-specific profiles after treatment. The data provided here will provide a valuable resource for future comparative studies across more diverse different geographic regions, for linkage studies that assess the impact of parasite genotype on immune / metabolic response and for use during the evaluation of new therapies against VL.

1 January 2025 in Journal of Tropical Medicine
Verified
Journal Article
Open access
CKCharles D. Kato
Charles D. Kato
AMAngella Musewa
Angella Musewa
TOTequiero A. Okumu
Tequiero A. Okumu
MMMargaret Mbuchi
Margaret Mbuchi
EAEdwinah Atusingwize
Edwinah Atusingwize
JOJames Robert Ochieng
James Robert Ochieng
To date, the reservoir host for visceral leishmaniasis, a neglected tropical disease caused by Leishmania donovani , is unknown, although studies pointing to dogs, domestic animals, and rodents are emerging. We aimed to investigate whether the dog ( Canis familiaris , Linnaeus, 1758) is a potential reservoir for L . donovan i in the Karamoja subregion of Uganda. Blood and lymph node aspirates were purposively collected from dogs ( n = 139) in disease endemic villages of Amudat and Moroto districts in August 2023. An indirect enzyme‐linked immunosorbent assay was used to detect anti‐ Leishmania IgG antibodies in serum. DNA extracted from lymph node aspirates was subjected to a polymerase chain reaction (PCR) targeting the rRNA internal transcribed spacer region of Leishmania species. The sera from 139 dogs did not demonstrate any evidence of circulating antibodies against Leishmania , as the optical density (OD) values were all below 0.25, lower than the threshold value of 0.45. Similarly, all the dog lymph node DNAs ( n = 139) were negative for Leishmania parasites. Although our results found no evidence to support dogs as reservoirs for L . donovani , in this study, further research utilizing larger sample sizes is recommended to confirm this finding. Furthermore, the presence of L . donovani in sand flies and other suspected reservoirs, such as domestic animals and wild rodents, requires further investigation.

20 October 2025 in bioRxiv
Verified
Preprint
Open access
MKMary Wandia Kivata
Mary Wandia Kivata
FEFredrick Lunyagi Eyase
Fredrick Lunyagi Eyase
WBWallace Bulimo
Wallace Bulimo
VOValerie Oundo
Valerie Oundo
EWEsther Waguche
Esther Waguche
MMMargaret Mbuchi
Margaret Mbuchi
Background: Surveillance of Neisseria gonorrhoeae strains, their antimicrobial resistance (AMR) profiles, and transmission dynamics is essential in the prevention and control of gonococcal infections. In Kenya, gonococcal molecular surveillance remains limited, leaving gaps in understanding circulating sequence types (STs). This study characterized Kenyan N. gonorrhoeae isolates using multiple molecular typing schemes. Methods: Illumina MiSeq generated paired-end sequence reads prepared from 35 N. gonorrhoeae isolates recovered from males and females from four different regions in Kenya were analyzed. Assemblies were analyzed using PubMLST tools for multi-locus sequence typing (MLST) and the N. gonorrhoeae sequence typing for antimicrobial resistance (NG-STAR) scheme. Multi-antigen sequence typing (NG-MAST) was carried out using the NG-MAST database. Phylogenetic relationships were assessed using concatenated NG-STAR loci and core genome-based analyses. Results: Twenty-two MLST STs were identified, including eight novel STs; ST-1932 was most frequent. NG-MAST revealed 29 STs, of which 26 were novel, with a newly described ST-19168 predominating in Nyanza region. NG-STAR identified 23 STs with variation across mtrR , penA , 23S rRNA , gyrA , parC, ponA , and porB. Phylogenetic analyses showed clustering of isolates into distinct groups with diverse AMR profiles. One cluster comprised isolates resistant to tetracycline and ciprofloxacin. No clear association was observed between MLST, NG-MAST, or NG-STAR types and specific AMR patterns. Conclusion: Kenyan N. gonorrhoeae strains are genetically diverse, with high numbers of novel NG-MAST and MLST STs. The lack of regional clustering and varied AMR profiles suggest widespread transmission of heterogeneous gonococcal populations. These findings underscore the importance of strengthened genomic surveillance to inform gonorrhea control strategies in Kenya.

19 May 2026 in PLOS ONE
Verified
Journal Article
Open access
MKMary Wandia Kivata
Mary Wandia Kivata
FEFredrick Lunyagi Eyase
Fredrick Lunyagi Eyase
WBWallace Bulimo
Wallace Bulimo
VOValerie Oundo
Valerie Oundo
EWEsther Waguche
Esther Waguche
MMMargaret Wanjiku Mbuchi
Margaret Wanjiku Mbuchi
Background: Surveillance of Neisseria gonorrhoeae strains, their antimicrobial resistance (AMR) profiles, and transmission dynamics is essential in the prevention and control of gonococcal infections. In Kenya, gonococcal molecular surveillance remains limited, leaving gaps in understanding circulating sequence types (STs). This study characterized Kenyan N. gonorrhoeae isolates using multiple molecular typing schemes. Methods: Illumina MiSeq generated paired-end sequence reads prepared from 35 N. gonorrhoeae isolates recovered from males and females from four different regions in Kenya were analyzed. Assemblies were analyzed using PubMLST tools for multi-locus sequence typing (MLST) and the N. gonorrhoeae sequence typing for antimicrobial resistance (NG-STAR) scheme. Multi-antigen sequence typing (NG-MAST) was carried out using the NG-MAST database. Phylogenetic relationships were assessed using concatenated NG-STAR loci and core genome-based analyses. Results: Twenty-two MLST STs were identified, including eight novel STs; ST-1932 was most frequent. NG-MAST revealed 29 STs, of which 26 were novel, with a newly described ST-19168 predominating in Nyanza region. NG-STAR identified 23 STs with variation across mtrR , penA , 23S rRNA , gyrA , parC, ponA , and porB. Phylogenetic analyses showed clustering of isolates into distinct groups with diverse AMR profiles. One cluster comprised isolates resistant to tetracycline and ciprofloxacin. No clear association was observed between MLST, NG-MAST, or NG-STAR types and specific AMR patterns. Conclusion: Kenyan N. gonorrhoeae strains are genetically diverse, with high numbers of novel NG-MAST and MLST STs. The lack of regional clustering and varied AMR profiles suggests widespread transmission of heterogeneous gonococcal populations. These findings underscore the importance of strengthened genomic surveillance to inform gonorrhea control strategies in Kenya.